Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 3 de 3
Filtrer
Plus de filtres










Base de données
Gamme d'année
1.
ACS Appl Mater Interfaces ; 13(2): 3237-3245, 2021 Jan 20.
Article de Anglais | MEDLINE | ID: mdl-33405504

RÉSUMÉ

Cationic polymers are promising antibacterial agents because bacteria have a low propensity to develop resistance against them, but they usually have low biocompatibility because of their hydrophobic moieties. Herein, we report a new biodegradable and biocompatible chitosan-derived cationic antibacterial polymer, 2,6-diamino chitosan (2,6-DAC). 2,6-DAC shows excellent broad-spectrum antimicrobial activity with minimum inhibitory concentrations (MICs) of 8-32 µg/mL against clinically relevant and multidrug-resistant (MDR) bacteria including Listeria monocytogenes, Staphylococcus aureus, Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter baumannii. Furthermore, 2,6-DAC shows an excellent synergistic effect with various clinically relevant antibiotics proved by decreasing the MICs of the antibiotics against MDR A. baumannii and methicillin-resistant Staphylococcus aureus to <1 µg/mL. In vivo biocompatibility of 2,6-DAC is proved by a dosage of 100 mg/kg compound via oral administration and 25 mg/kg compound via intraperitoneal injection to mice; 2,6-DAC does not cause any weight loss and any significant change in liver and kidney biomarkers or the important blood electrolytes. The combinations of 2,6-DAC together with novobiocin and rifampicin show >2.4 log10 reduction of A. baumannii in murine intraperitoneal and lung infection models. The novel chitosan derivative, 2,6-DAC, can be utilized as a biocompatible broad-spectrum cationic antimicrobial agent alone or in synergistic combination with various antibiotics.


Sujet(s)
Antibactériens/composition chimique , Antibactériens/pharmacologie , Bactéries/effets des médicaments et des substances chimiques , Chitosane/analogues et dérivés , Chitosane/pharmacologie , Animaux , Infections bactériennes/traitement médicamenteux , Synergie des médicaments , Femelle , Humains , Staphylococcus aureus résistant à la méticilline/effets des médicaments et des substances chimiques , Souris de lignée BALB C , Tests de sensibilité microbienne
2.
ACS Appl Mater Interfaces ; 10(24): 20356-20367, 2018 Jun 20.
Article de Anglais | MEDLINE | ID: mdl-29806938

RÉSUMÉ

Multidrug resistance and the refractory character of bacterial biofilms are among the most difficult challenges in infection treatment. Current antimicrobial strategies typically are much more effective for prevention of biofilm formation than for eradication of established biofilms; these strategies also leave dead bacteria and endotoxin in the infection site, which impairs healing. We report a novel hydrogel that eradicates biofilm bacteria by non-leaching-based debridement followed by ex situ contact-killing (DESCK) away from the infection site. The debridement effect is likely due to the high water swellability and microporosity of the cross-linked network which is made from polyethylene glycol dimethacrylate tethered with a dangling polyethylenimine (PEI) star copolymer. The large pore size of the hydrogel makes the cationic pore walls highly accessible to bacteria. The hydrogel also degrades in the presence of infection cells, releasing star cationic PEI into the infection site to contact-kill bacteria remaining there. DESCK hydrogel effectively kills (>99.9% reduction) biofilms of methicillin-resistant Staphylococcus aureus (MRSA) and carbapenem-resistant Pseudomonas aeruginosa (CR-PA) and Acinetobacter baumannii in a murine excisional wound infection model. Silver-based wound dressings (controls) showed almost no killing of CR-PA and MRSA biofilms. This DESCK hydrogel greatly reduces the bioburden and inflammation and promotes wound healing. It has great potential for diverse infection treatment applications.


Sujet(s)
Biofilms , Animaux , Antibactériens , Débridement , Résistance bactérienne aux médicaments , Multirésistance aux médicaments , Hydrogels , Staphylococcus aureus résistant à la méticilline , Souris , Pseudomonas aeruginosa , Infection de plaie
3.
Chem Asian J ; 3(2): 473-84, 2008 Feb 01.
Article de Anglais | MEDLINE | ID: mdl-18203216

RÉSUMÉ

Pd(II)-catalyzed cyclizations of chiral epsilon-, zeta-, and eta-hydroxy-alpha,beta-unsaturated alcohols are described. The reactions took place stereospecifically to give chiral 2,5-disubstituted tetrahydrofurans, 2,6-disubstituted tetrahydropyrans, and 2,7-disubstituted oxepanes, respectively. The chirality of the carbon center of the chiral allylic alcohol is transferred stereospecifically to the carbon center of the newly generated oxacyclic ring. A plausible reaction mechanism involves 1) chiral-allylic-alcohol-induced syn facioselective formation of a Pd pi-complex, 2) syn oxypalladation, and 3) syn elimination of PdCl(OH), which provide a rational account for the stereochemical results.


Sujet(s)
Oxygène/composition chimique , Palladium/composition chimique , Alcools/composition chimique , Catalyse , Cyclisation , Structure moléculaire , Stéréoisomérie
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE
...